The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.
| Image |  |
|---|---|
| Description | scientific article published on April 2010 |
| Author/s |
author: Juan Angel Recio Marta López-Fauqued Javier Hernandez-Losa |
| Publication date | April 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |